Kynurenine Pathway Metabolites as Biomarkers in Alzheimer's Disease

Alzheimer's disease (AD) is a progressive neurodegenerative disorder that deteriorates cognitive function. Patients with AD generally exhibit neuroinflammation, elevated beta-amyloid (Aβ), tau phosphorylation (p-tau), and other pathological changes in the brain. The kynurenine pathway (KP) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Yuqing, Xie, Shan, He, Yanyun, Xu, Manru, Qiao, Xi, Zhu, Yue, Wu, Wenbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791723/
https://www.ncbi.nlm.nih.gov/pubmed/35096208
http://dx.doi.org/10.1155/2022/9484217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791723/
https://www.ncbi.nlm.nih.gov/pubmed/35096208
http://dx.doi.org/10.1155/2022/9484217

Ejemplares similares